Image

Neoadjuvant Therapy of HAIC?GEMOX? Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors?NEO-ERA-01 Study

Recruiting
18-75 years
Both
Phase 2
  • Simplified (AI rewritten)
  • Technical (Original)

This study is testing a new way to help treat a type of liver cancer called intrahepatic cholangiocarcinoma (a cancer in the bile ducts inside the liver). The study uses medicines called Lenvatinib and Adebrelimab along with a special type of chemotherapy called hepatic arterial infusion chemotherapy (HAIC). The goal is to see if this treatment helps the cancer shrink before surgery, making surgery more successful.

Participants will receive 2-4 cycles of the treatment before their surgery. The main things this study wants to find out are how well the treatment works and how safe it is for the patients.

  • **Commitment**: Participants will undergo 2-4 cycles of treatment before surgery.
  • **Eligibility**: Participants must be aged 18-75, and have a specific type of high-risk biliary tract cancer.
  • **Safety**: The study will closely monitor the safety and effects of the treatment.
Print
Study details
    Biliary Tract Carcinoma

NCT06208462

The First Affiliated Hospital with Nanjing Medical University

24 January 2024

Contact a study center
Not finding the right Trial?

You can also call our Patient navigators who can help you to find the right trial.

Call now
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.